• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

噬血细胞性淋巴组织细胞增生症(HLH)的动物模型:CD8 + T细胞和干扰素γ对该病症至关重要。

An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.

作者信息

Jordan Michael B, Hildeman David, Kappler John, Marrack Philippa

机构信息

Integrated Department of Immunology, University of Colorado Health Sciences Center, Denver, USA.

出版信息

Blood. 2004 Aug 1;104(3):735-43. doi: 10.1182/blood-2003-10-3413. Epub 2004 Apr 6.

DOI:10.1182/blood-2003-10-3413
PMID:15069016
Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a rare disorder with familial and acquired forms. The familial form is associated with mutations in the perforin gene and both forms are associated with severe defects in lymphocyte cytotoxic function. We examined perforin-deficient mice as a model of HLH in order to gain insight into this poorly understood disorder. While these mice do not spontaneously develop HLH-like symptoms, we found that they manifest all of the features of HLH after infection with lymphocytic choriomeningitic virus (LCMV). Following LCMV infection, perforin-deficient mice develop fever, splenomegaly, pancytopenia, hypertriglyceridemia, hypofibrinogenemia, and elevation of multiple serum cytokine levels, and hemophagocytosis is evident in many tissues. Investigation into how this phenotype develops has revealed that CD8+ T cells, but not natural killer (NK) cells, are necessary for the development of this disorder. Cytokine neutralization studies have revealed that interferon gamma (IFNgamma) is uniquely essential as well. Finally, the excessive amount of IFNgamma seen in affected mice appears to be driven by increased antigen presentation to CD8+ T cells. These studies provide insight into the pathophysiology of HLH, and provide new targets for specific therapeutic intervention in this fatal disorder.

摘要

噬血细胞性淋巴组织细胞增生症(HLH)是一种罕见的疾病,有家族性和获得性两种形式。家族性形式与穿孔素基因突变有关,两种形式均与淋巴细胞细胞毒性功能的严重缺陷有关。我们研究了穿孔素缺陷小鼠作为HLH的模型,以便深入了解这种了解甚少的疾病。虽然这些小鼠不会自发出现HLH样症状,但我们发现它们在感染淋巴细胞性脉络丛脑膜炎病毒(LCMV)后会表现出HLH的所有特征。LCMV感染后,穿孔素缺陷小鼠会出现发热、脾肿大、全血细胞减少、高甘油三酯血症、低纤维蛋白原血症以及多种血清细胞因子水平升高,并且在许多组织中可见噬血细胞现象。对这种表型如何发展进行的研究表明,CD8 + T细胞而非自然杀伤(NK)细胞是这种疾病发展所必需的。细胞因子中和研究表明,γ干扰素(IFNγ)同样具有独特的必要性。最后,在受影响小鼠中观察到的过量IFNγ似乎是由向CD8 + T细胞的抗原呈递增加所驱动。这些研究为HLH的病理生理学提供了见解,并为这种致命疾病的特异性治疗干预提供了新的靶点。

相似文献

1
An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.噬血细胞性淋巴组织细胞增生症(HLH)的动物模型:CD8 + T细胞和干扰素γ对该病症至关重要。
Blood. 2004 Aug 1;104(3):735-43. doi: 10.1182/blood-2003-10-3413. Epub 2004 Apr 6.
2
Trigger-dependent differences determine therapeutic outcome in murine primary hemophagocytic lymphohistiocytosis.触发依赖性差异决定了小鼠原发性噬血细胞性淋巴组织细胞增生症的治疗效果。
Eur J Immunol. 2020 Nov;50(11):1770-1782. doi: 10.1002/eji.201948123. Epub 2020 Jun 2.
3
IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis.高活性 CD8 T 细胞消耗 IL-2 可诱导噬血细胞性淋巴组织细胞增多症患者调节性 T 细胞功能障碍。
J Allergy Clin Immunol. 2016 Jul;138(1):200-209.e8. doi: 10.1016/j.jaci.2015.12.1314. Epub 2016 Mar 4.
4
IFN-γ and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis.IFN-γ 和 CD25 在噬血细胞性淋巴组织细胞增生症中驱动不同的病理特征。
J Allergy Clin Immunol. 2019 Jun;143(6):2215-2226.e7. doi: 10.1016/j.jaci.2018.10.068. Epub 2018 Dec 19.
5
Mouse Cytomegalovirus Infection in BALB/c Mice Resembles Virus-Associated Secondary Hemophagocytic Lymphohistiocytosis and Shows a Pathogenesis Distinct from Primary Hemophagocytic Lymphohistiocytosis.BALB/c小鼠的鼠巨细胞病毒感染类似于病毒相关的继发性噬血细胞性淋巴组织细胞增生症,并显示出与原发性噬血细胞性淋巴组织细胞增生症不同的发病机制。
J Immunol. 2016 Apr 1;196(7):3124-34. doi: 10.4049/jimmunol.1501035. Epub 2016 Feb 22.
6
Genetic Deficiency of Interferon-γ Reveals Interferon-γ-Independent Manifestations of Murine Hemophagocytic Lymphohistiocytosis.干扰素-γ 基因缺陷揭示了鼠噬血细胞性淋巴组织细胞增多症的干扰素-γ 非依赖性表现。
Arthritis Rheumatol. 2020 Feb;72(2):335-347. doi: 10.1002/art.41076. Epub 2019 Dec 15.
7
Hemophagocytic lymphohistiocytosis in syntaxin-11-deficient mice: T-cell exhaustion limits fatal disease.Syntaxin-11 缺陷小鼠中的噬血细胞性淋巴组织细胞增生症:T 细胞衰竭限制致命疾病。
Blood. 2013 Jan 24;121(4):604-13. doi: 10.1182/blood-2012-07-441139. Epub 2012 Nov 27.
8
CD8 T Cell Biology in Cytokine Storm Syndromes.细胞因子风暴综合征中的 CD8 T 细胞生物学。
Adv Exp Med Biol. 2024;1448:129-144. doi: 10.1007/978-3-031-59815-9_10.
9
ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice.ST2在小鼠中导致T细胞过度活化和致命性噬血细胞性淋巴组织细胞增生症。
Blood. 2016 Jan 28;127(4):426-35. doi: 10.1182/blood-2015-07-659813. Epub 2015 Oct 30.
10
Down-regulation of CD5 expression on activated CD8+ T cells in familial hemophagocytic lymphohistiocytosis with perforin gene mutations.家族性噬血细胞性淋巴组织细胞增生症伴穿孔素基因突变患者激活的 CD8+T 细胞上 CD5 表达下调。
Hum Immunol. 2013 Dec;74(12):1579-85. doi: 10.1016/j.humimm.2013.09.001. Epub 2013 Sep 16.

引用本文的文献

1
Clinical and genetic features of UNC13D deficiency with hypogammaglobulinemia.伴有低丙种球蛋白血症的UNC13D缺乏症的临床和遗传特征
Front Immunol. 2025 Aug 18;16:1628507. doi: 10.3389/fimmu.2025.1628507. eCollection 2025.
2
Tislelizumab-induced hemophagocytic lymphohistiocytosis in a patient with microsatellite instability-high colon cancer and coexisting systemic lupus erythematosus: a case report and literature review.替雷利珠单抗诱导的噬血细胞性淋巴组织细胞增生症在一名微卫星高度不稳定的结肠癌合并系统性红斑狼疮患者中的病例报告及文献复习
Front Oncol. 2025 Aug 6;15:1585133. doi: 10.3389/fonc.2025.1585133. eCollection 2025.
3
Latest updates on pathogenesis mechanisms and management strategies for cytokine release syndrome, neurotoxicity, and hemophagocytic lymphohistiocytosis related to CAR-T cell therapies.
嵌合抗原受体T细胞(CAR-T)疗法相关的细胞因子释放综合征、神经毒性和噬血细胞性淋巴组织细胞增生症的发病机制及管理策略的最新进展
Ann Hematol. 2025 Jun 19. doi: 10.1007/s00277-025-06467-y.
4
Promising Targeted Therapies for Hemophagocytic Lymphohistiocytosis: A Translational Perspective Based on Immunopathology.噬血细胞性淋巴组织细胞增生症的有前景的靶向治疗:基于免疫病理学的转化视角
Clin Rev Allergy Immunol. 2025 Jun 9;68(1):56. doi: 10.1007/s12016-025-09068-9.
5
The pathophysiology of hemophagocytic lympho-histiocytosis (HLH) syndrome and insights from animal models.噬血细胞性淋巴组织细胞增生症(HLH)综合征的病理生理学及来自动物模型的见解。
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxaf036.
6
Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report.emapalumab治疗实体瘤CAR-T相关严重细胞因子释放综合征:一例报告
Front Oncol. 2025 Apr 1;15:1543622. doi: 10.3389/fonc.2025.1543622. eCollection 2025.
7
Deep insight into cytokine storm: from pathogenesis to treatment.深入洞察细胞因子风暴:从发病机制到治疗。
Signal Transduct Target Ther. 2025 Apr 16;10(1):112. doi: 10.1038/s41392-025-02178-y.
8
T-ing up the storm: pathogenic cycling lymphocytes in the biology of macrophage activation syndrome.引发风暴:巨噬细胞活化综合征生物学中的致病性循环淋巴细胞
Pediatr Rheumatol Online J. 2025 Mar 17;23(1):29. doi: 10.1186/s12969-025-01081-8.
9
Anakinra for dengue patients with hyperinflammation: protocol for a randomized double-blind placebo-controlled trial.阿那白滞素用于治疗登革热高炎症患者:一项随机双盲安慰剂对照试验方案
Wellcome Open Res. 2024 Nov 22;9:689. doi: 10.12688/wellcomeopenres.21017.1. eCollection 2024.
10
PRMT5 inhibition reduces hyperinflammation in a murine model of secondary hemophagocytic lymphohistiocytosis.PRMT5抑制可减轻继发性噬血细胞性淋巴组织细胞增生症小鼠模型中的过度炎症反应。
Blood Adv. 2025 May 27;9(10):2379-2392. doi: 10.1182/bloodadvances.2024013651.